NCT06910020

Brief Summary

Following CABG surgery, patients are at risk for several complications. One of the most common complications is postoperative pulmonary complications, which include atelectasis and dyspnea. These complications cause prolonged ICU length of stay and increased health care costs. Several studies recommended the active cycle of breathing technique as a method that increases secretion removal and improves lung functions, thus reducing the incidence of postoperative pulmonary complications. Our study aims to investigate the effect of the active cycle of breathing technique on coronary artery bypass graft patients' outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 18, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2025

Completed
Last Updated

June 10, 2025

Status Verified

March 1, 2025

Enrollment Period

8 months

First QC Date

March 18, 2025

Last Update Submit

June 8, 2025

Conditions

Keywords

CABGACBTPostoperative Pulmonary ComplicationsChest tube durationHemodynamic parametersChest expansion

Outcome Measures

Primary Outcomes (8)

  • Atelectasis

    Atelectasis will be assessed using chest X-rays.

    The first three postoperative days

  • Dyspnea

    Dyspnea level will be assessed using the modified Borg scale.

    The first three postoperative days

  • Functional capacity

    Functional capacity will be assessed using the six-minute walk test

    The first three postoperative days

  • Hemodynamic parameters

    Hemodynamic parameters will include respiratory rate expressed as the number of cycles per minute, which will be assessed using the cardiac monitor

    The first three postoperative days

  • Chest expansion

    Chest expansion will be measured at three points (axillary, xiphoid point, and umbilical level) using a measuring tape in centimeters.

    The first three postoperative days

  • Duration of chest tube

    Duration of chest tube

    Up to 1 week

  • Length of ICU stay

    Measure the duration of the patient's ICU stay

    For up to 1 week

  • Hemodynamic Parameters

    Hemodynamic parameters will include oxygen saturation, which will be assessed using the pulse oximeter and will be expressed as a percentage %

    For the first three postoperative days

Study Arms (2)

Active Cycle of Breathing Technique

EXPERIMENTAL

Patients who will perform ACBT exercises in addition to the routine ICU care.

Other: Active Cycle of Breathing Technique

Control Group

NO INTERVENTION

Patients who will receive routine ICU care (chest physiotherapy and incentive spirometer) without ACBT.

Interventions

* Patients will assume the sitting position and relax their shoulders, then perform the following: 1. Breathing control (abdominal breathing) 2. Chest expansion (thoracic breathing) 3. Huff cough (forced expiratory technique) * After completing the above actions, patients will be asked to cough up the residual deep sputum to promote pulmonary expansion. * The ACBT intervention will be performed for three days, each day two sessions, each session three courses, with 10 minutes of rest between them as needed.

Active Cycle of Breathing Technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any adult patient who will undergo CABG

You may not qualify if:

  • Mechanically ventilated patients on the first postoperative day.
  • Patients with preoperative lung collapse or pleural effusion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiothoracic and Vascular Surgery Center

Al Mansurah, Dakahliya, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Demonstrator of Critical Care and Emergency Nursing

Study Record Dates

First Submitted

March 18, 2025

First Posted

April 4, 2025

Study Start

January 10, 2024

Primary Completion

September 20, 2024

Study Completion

May 25, 2025

Last Updated

June 10, 2025

Record last verified: 2025-03

Locations